U.S Influenza Vaccines Market Worth US$ 8.3 billion by 2031

DELHI, India - March 16, 2023 - PRLog -- The influenza vaccines market in the United States was valued at US$ 3,962 billion in 2022 and is expected to reach US$ 8,347 billion by 2031, registering a CAGR of 8.6% during the forecast period.

Rapid market expansion is primarily due to increased research and development, the introduction of quadrivalent influenza vaccines, the aging population, and vaccine awareness. In addition, expanded recommendations from government and advisory bodies to get influenza vaccines are driving market growth in the United States.

Influenza is the second leading cause of death from vaccine-preventable disease in the United States after COVID-19. Rates of seasonal influenza infection are highest in children, but the risks for complications, hospitalizations, and deaths are higher in adults 65 years of age and older, children younger than 5 years, pregnant women, and people of any age with conditions that place them at increased risk for influenza complications.

The report on the influenza vaccines market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, forecasts, and trends in the influenza vaccines market in the United States during 2018-2031. In addition, the report is a collective presentation of primary and secondary research findings.

More Details @ https://dpiresearch.com/united-states-influenza-vaccines-...